Comparative Assessment of the Quality Control Measurements of Multisource Ofloxacin Tablets Marketed in Nigeria

Abstract

This study aimed at evaluating some quality control parameters to compare the quality, safety, and efficacy of nine brands of ofloxacin tablets available in the Nigerian market. The physicochemical parameters and assay of the nine brands of ofloxacin tablets were assessed through the evaluation of uniformity of tablet weight, friability, hardness, disintegration, and assay of active ingredients according to established methods. The dissolution rate and disintegration time were determined in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) without enzymes. The concepts of dissolution efficiency (DE) and predicted availability equivalence (PAE) were used to estimate the likely in vivo bioavailability. All brands complied with the official specification for uniformity of weight, friability, and disintegration. The disintegration test revealed that the drugs had higher disintegration times in SGF (7.0 ± 0.95) relative to those in SIF (5.0 ± 2.55). The dissolution profiles in SGF showed that only one sample attained 70% dissolution in less than 45 min and the other 5 samples in 1 h, while in SIF, four samples attained 70% dissolution in 45 min and all samples in 1 h. The UV spectrophotometric assay of ofloxacin tablets revealed that three samples contained over 95% (w/w) of labeled chemical content. The PAE in SGF indicated over 90% release from five samples, while it revealed over 70% release in SIF from three samples out of the aforementioned. Only four of the brands considered in this study demonstrated comparable quality standards. The method is simple and rugged for both routine analysis and evaluation of the dissolution pattern of ofloxacin tablets as in vitro tests for batch-to-batch quality control assessment.

In-vitro study of quality control parameters of three different brands of azithromycin tablets

“…They must be identical in strength, quality, purity, active ingredient release profile and also in the same dosage form, for the same route of administration. [6][7][8][9] Though these information are collected during clinical trials and to some extent by scientific literature but the data obtained by postmarketed monitoring helps in product improvement, development of standards and regulations. It is therefore imperative to conduct postmarketing surveillance or monitoring of approved medicines in order to assess their quality, therapeutic effectiveness and safety of medicines for the public.…”

Review of the Quality of Pediatric Medications in Developing Countries

“…The 70 included studies examined 75 of the 267 (28.1%) medicines listed on the EMLC. Many studies tested quality with small sample sizes ( n ≤ 10) 7–29. Of the 262 individual medicine tests, 56.5% (148/262) had sample sizes of ≤10.…”

The Effect of Food on the Disintegration Time and Dissolution Profile of Artemether-Lumefantrine Tablet

“…The chemical content determination of artemether content using the titrimetric and spectrophotometric methods gave values that had positive linear relationship. The likelihood of interference by the presence of the food particles may however give misleading results with titrimetry, if this method was used to evaluate the drug release 19 . The analysis might be cumbersome if blanks containing the food particles were designed to correct for errors due to food particle interference and to standardize the determinations.…”